Ultimate sensitivity with a sure grip
The Gammex® PF Sensitive™ glove is
25% thinner than a standard surgical
latex glove such as the Gammex® PF.
This results in a highly superior level
of tactile sensitivity (see thickness
comparison table) allowing most
accurate manipulation of delicate
The glove’s textured surface is
designed to provide a sure and
precise grip even during the most
delicate procedures in both wet and
comfort and ease
Because of its very thin latex
formulation and Ansell’s great
attention to every aspect of design,
the Gammex® PF Sensitive™ glove
feels like a second skin. It offers
among other qualities comfort,
elasticity and sensitivity, features the
Gammex® range is renowned for.
Moreover, the adhesive band at the
top of the cuff maintains good contact
with the surgical gown preventing
the glove from rolling down, while
its brown colour reduces the adverse
effect of ref lections from the strong
light sources used in microsurgical
In addition, chlorination treatment
inside the glove makes it easy to don
in dry conditions.
Users of Ansell Gammex® PF
Sensitive™ benefit from reduced
risk of latex sensitisation. This is
ensured through leaching processes
and post-production washing
cycles, such as Ansell’s Protein and
Endogenous Allergen Reduction
Leaching (P.E.A.R.L) technology.
HPLC and Modified Lowry methods
are used to measure protein content.
Additionally, the manufacturing
process is designed to reduce
chemical residues to the minimum.
Safety is assured through quality
controls before, during and after final
packaging, guaranteeing a low risk of
pinholes and high barrier protection.
- Quality control is assured, based
on AQL inspection procedures
(water leak tested): conformity to European norm
EN 455-1: inspection level I AQL 1.5, manufacturing final release:
inspection level I AQL 1.0, in process control before packaging:
inspection level II AQL 0.65
- Good tear resistance and very
favourable strength-to-thickness ratio
provide an assured protective barrier.
- Strong resistance to viral penetration
is verified by extensive
bacteriophage test results
(see the Ansell AVPP brochure).
- Greater patient protection, based on
close monitoring of pyrogen and
endotoxin levels (biocompatibility test
as per ISO 10993).
- Low particle levels result from
limited residual production-based
powder (releasing agent).
- Easy shelf identification, plus links
to manufacturing data supported
by lot numbers.